Clinical trial
Study to Evaluate Changes in CD4 on Replacing TDF With ABC or DDI+TDF With…
NCT00338390 · Hospital de Granollers, Other · Completed
Key facts
| NCT number | NCT00338390 |
|---|---|
| Title | Study to Evaluate Changes in CD4 on Replacing TDF With ABC or DDI+TDF With ABC+3TC |
| Official title | Study of Changes in CD4 Lymphocyte Count in Patients With a HAART Regimen Including DDI + Tenofovir and With Viral Suppression Following the Replacement of Tenofovir With Abacavir Once Daily or Following the Double Replacement of DDI + Tenofovir With Abacavir + Lamivudine in a Single Tablet |
| Lead sponsor | Hospital de Granollers, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Abacavir, Didanosine, Abacavir+Lamivudine |
| Enrollment | 75 |
| Start date | Apr 1, 2005 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Jun 20, 2006 |
| Last update posted | Mar 24, 2015 |
| Countries | Spain |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: